Financhill
Back

Arcus Biosciences 10K Form

Sell
29

RCUS
Arcus Biosciences

Last Price:
20.47
Seasonality Move:
48.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RCUS News And Ratings

See the #1 stock for the next 7 days that we like better than RCUS

RCUS Financial Statistics

Sales & Book Value

Annual Sales: $382.88M
Cash Flow: $-82.28M
Price / Cash Flow: 3.66
Annual Sales: $9.68
Price / Book: 2.12

Profitability

EPS (TTM): 0.92000
Net Income (TTM): $79.82M
Gross Margin: --
Return on Equity: 11.01%
Return on Assets: 5.83%

Arcus Biosciences Earnings Forecast

Key Arcus Biosciences Financial Ratios

  • The Research & Development expenses have been 66.95% of Revenue.
  • The Interest Expense is 0.49% of Operating Income.
  • The Net Earning history of RCUS is 13.80% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Arcus Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Healthcare
Current Symbol: RCUS
CUSIP: 03969F
Website: arcusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.21
Quick Ratio: 6.09

Price-to-Earnings

Trailing P/E Ratio: 28.89
Forward P/E Ratio: 0

RCUS Technical Analysis vs Fundamental Analysis

Sell
29
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy or a Sell?

  • Arcus Biosciences stock is rated a Sell
    The current Arcus Biosciences [RCUS] share price is $20.51. The Score for RCUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.